Respiratory Bronchiolitis-associated Interstitial Lung Disease with Unusual Histopathological Findings by Tomari Shinya et al.
Acta Med. Nagasaki 48: 175-177
Case Report 
Respiratory Bronchiolitis-associated Interstitial Lung Disease with 
Unusual Histopathological Findings
Shinya TOMARI, Hiroto MATSUSE, Hiroshi MUKAE, Shigeru KOHNO
Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, JAPAN
 Respiratory bronchiolitis-associated interstitial lung dis-
ease (RB-ILD) is a mild inflammatory reaction commonly 
seen in asymptomatic young male cigarette smokers. This 
report describes unusual pathological findings in a 63-year-
old Japanese female with RB-ILD. She had a 40 pack-year 
smoking history. Chest computed tomography showed multi-
ple patchy shadows, especially in the right lower lobe. 
Diagnosis could not be established by bronchoalveolar 
lavage and transbronchial lung biopsy. Thoracoscopic lung 
biopsy was performed from right S5 and S9, which demon-
strated the typical pathological findings of RB-ILD, includ-
ing the presence of pigmented macrophages within respira-
tory bronchioles, thickening of alveolar septa by fibrosis, 
accumulation of intrapulmonary blue bodies and lack of 
granulomatous changes. Our patient had atypical RB-ILD 
based on old age at presentation (commonly -40 years of 
age), marked fibrosis and presence of numerous blue bodies. 
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mented macrophages within the respiratory bronchi-
oles and adjacent air spaces, associated with mild 
thickening of the peribronchiolar interstitium 2 - 5' 
 We describe here a case of atypical RB-ILD in a 
middle-aged woman with numerous intrapulmonary 
blue bodies, accumulation of pigmented macrophages 




 Respiratory bronchiolitis associated interstitial lung 
disease (RB-ILD) usually occurs in cigarette smokers 
who are younger than 60 years of age, and the clinical 
features of this disease include productive cough, 
dyspnea, abnormal shadows on the chest roentgenogram, 
and abnormal lung function tests'-'). RB-ILD is, how-
ever, diagnosed pathologically by the presence of pig-
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 A 63-year-old woman was referred to the outpatient 
clinic on August 2000 because of an abnormal shadow 
found on the chest X-ray on a routine medical exami-
nation. She complained of cough and sputum for 8 
months prior to the visit. Chest computed tomography 
(CT) revealed that the abnormal shadow was a bone 
island, but it also showed multiple patchy shadows in 
both lung fields. For further examination of these 
multiple shadows, she was transferred to our hospital 
on September 2000. 
 She was a habitual smoker (40-pack-year smoking 
history) but there was no evidence of illicit drug use, 
allergy, or history of travel to a foreign country. She was 
a housewife and had kept a dog during the past 25 years. 
On admission to our hospital, chest auscultation re-
vealed fine crackles at the base of the lung, bilaterally. 
Arterial blood gas analysis while breathing room air 
showed Pa02 of 85.3 Torr, PaCO2 40.4 Torr, pH 7.472, 
and Sa02 of 97.5%. Laboratory tests including leucocyte 
count, C-reactive protein, autoantibodies to deoxyribo-
nucleic acid (DNA), double stranded DNA, rheumatoid 
factor, KL-6, surfactant protein-D, angiotensin convert-
ing enzyme, lysozyme, cartinoembryonic antigen and 
IgE were normal. Urinalysis and stool examination 
were also normal. Pulmonary function tests showed 
forced vital capacity (FVC) of 2.30 (99.6% pred); forced 
expiratory volume in one second (FEV 1) 1.70 (87.8% 
pred); and a diffusing capacity for carbon monoxide
Figure 1. Chest CT scan taken on admission (September 
2000), showing multiple ground glass opacities mainly in the 
middle and lower lobes bilaterally.
Figure 2. Low magnification of biopsy specimen from rt. 
S5 and S9 showing a collection of intra-alveolar macrophages 
in the centre of a bronchiole and alveolar duct, and fibrosis 
along the alveoli with hyperplasia of smooth muscles. These 
changes were not diffuse.
Figure 3. Biopsy specimen from rt. S5 and S9 showing blue 
bodies with fibrosis (low magnification). Inset: high magnifi-
cation of blue body.
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(DLCO) of 10.55 ml/min/mmHg (69.3% pred). 
 A chest radiograph revealed a small nodule (a bone 
island) at the left upper lung field. Chest CT scan 
showed multiple patchy ground glass opacities, 
bilaterally, especially in the middle and lower lobes 
(Fig. 1). On September 28, bronchoalveolar lavage 
(BAL) and transbronchial lung biopsy (TBLB) were 
performed. Analysis of BAL fluid showed total cell 
count of 412 cells/,oL (differential: macrophages 90.0%, 
neutrophils 1.6%, lymphocytes 7.8%, and eosinophils 
0.7%). These findings were compatible with chronic 
smoking and were considered to be non-specific. The 
pathological findings of TBLB showed the presence of 
blue bodies with no other specific findings. Because of 
persistence of symptoms and lack of definite diagno-
sis, on October 13, the patient underwent video-
assisted thoracoscopic lung biopsy from rt. S5 and S9 
to establish the diagnosis. The main pathological find-
ings were the presence of macrophages containing 
brown or black pigments within the respiratory bron-
chioles and fibrosis along the alveoli with hyperplasia 
of smooth muscles. Based on the patchy distribution 
of the lesion (Fig. 2), the diagnosis of RB-ILD was es-
tablished. However, this case was particularly different 
from typical cases of RB-ILD because of the marked 
fibrosis and the presence of numerous intrapulmonary 
blue bodies (Fig. 3). 
 The patient stopped smoking since admission, and 
her symptoms subsequently subsided. The multiple 
patchy shadows on chest CT also decreased 3 months 
later.
Discussion
 Niewoehner et al.'' were the first group to describe 
respiratory-bronchiolitis in autopsies of young ciga-
rette smokers. The pathological findings of RB-ILD in-
clude the presence of pigmented macrophages within 
the respiratory bronchioles and adjacent air spaces as-
sociated with mild thickening of the peribronchiolar 
interstitium 2 -6). Therefore, the diagnosis of this dis-
ease cannot be established by chest roentgenogram, 
CT6, or BAL; rather, either open lung biopsy or video-
assisted thoracoscopic lung biopsy is required to es-
tablish the diagnosis. 
 An important differential diagnosis of RB-ILD is 
desquamative interstitial pneumonia/alveolar macro-
phage pneumonia (DIP/AMP) 2 - 6' . Since DIP/AMP 
shows intrapulmonary pigmented macrophages and in-
terstitial fibrosis, both of which are also commonly 
observed in RB-ILD, it is often difficult to distinguish 
RB-ILD from DIP/AMP. Previous reports indicated
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that the pathological changes in the lung are re-
stricted to the peribronchiolar areas in RB-ILD, 
whereas they are more diffuse throughout the alveolar 
septa of the lobules in DIP/AMP". Another important 
feature that distinguishes RB-ILD from DIP/AMP is 
the good prognosis without corticosteroid therapy. In 
general, DIP/AMP is a progressive disease even in pa-
tients receiving treatment (eg, corticosteroids) 4 > . In 
contrast, patients with RB-ILD show spontaneous im-
provement after cessation of smoking without any 
medications". Thus, the final diagnosis in our case 
was RB-ILD since pigmented macrophages and inter-
stitial fibrosis were restricted to peribronchiolar areas, 
and clinical symptoms and signs improved after cessa-
tion of smoking. 
 However, the histopathological findings in our case 
were different from those of previously reported cases, 
including the marked fibrosis of centrilobular distribu-
tion and the abundant intrapulmonary blue bodies. 
The latter are intra-alveolar basophilic concretions, and 
are often observed in DIP/AMP, pneumoconiosis, lung 
cancer, pulmonary fibrosis and pulmonary talcosis' -'°)
Although the exact aetiology of blue bodies is un-
known, the relation between pulmonary inflammation 
and accumulation of blue bodies has been reported", 
although Kung et al." failed to find a significant rela-
tion between pulmonary inflammation and intrapul-
monary blue bodies. Since no inflammation was de-
tected in the lung biopsy specimen in our case, it is 
not clear whether the marked fibrosis and numerous 
blue bodies were associated with pulmonary inflam-
mation prior to the development of the disease. The 
present case was diagnosed as RB-ILD based on the 
patchy distribution of the lesion and clinical course. 
However, marked fibrosis and blue bodies may rather 
support the diagnosis of DIP/AMP. It is also possible 
that relatively long smoking history might cause 
marked fibrosis in the present case. Marked fibrosis 
may be associated with the presence of blue bodies. 
 Ryu et al." reviewed smoking-related interstitial 
lung diseases. They indicated that RB-ILD usually oc-
curs in smokers aged around 40 years. However, our 
patient was 63 years old, thus this case could b e pos-
sibly labelled as atypical RB-ILD. To our knowledge, 
this is the first case of RB-ILD with marked pulmo-
nary fibrosis and numerous intrapulmonary blue bod-
ies. Identification of similar cases in the future may 
allow determination of the exact aetiology of intrapul-
monary blue bodies of RB-ILD.
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